SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914062-13-000197
Filing Date
2013-06-04
Accepted
2013-06-04 17:59:14
Documents
2
Period of Report
2013-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4340
2 CONFIRMING STATEMENT csmauldin.txt EX-24 1347
  Complete submission text file 0000914062-13-000197.txt   7117
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3204 BEVERLY DRIVE DALLAS TX 75205
Business Address
MAULDIN JOHN F (Reporting) CIK: 0001522480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 13892531